Endotoxin suppresses rat hepatic low-density lipoprotein receptor expression

W Liao, M Rudling, B Angelin, W Liao, M Rudling, B Angelin

Abstract

Endotoxin induces hyperlipidaemia in experimental animals. In the current study, we investigated whether endotoxin alters hepatic low-density lipoprotein (LDL) receptor expression in rats. Endotoxin treatment suppressed hepatic LDL receptor expression in a dose- and time-dependent manner. Eighteen hours after intraperitoneal injection of increasing amounts of endotoxin, LDL receptor and its mRNA levels were determined by ligand blot and solution hybridization respectively. LDL receptor expression was inhibited by about 70% at a dose of 500 micrograms/100 g body weight. However, LDL receptor mRNA levels were markedly increased in all endotoxin-treated groups at this time point (by 83-136%; P < 0.001). Time-course experiments showed that LDL receptor expression was already reduced by 48% 4 h after endotoxin injection and was maximally reduced (by 63-65%) between 8 and 18 h. Changes in hepatic LDL receptor mRNA showed a different pattern. By 4 h after endotoxin injection, LDL receptor mRNA had decreased by 78% (P < 0.001). However, by 8 h after endotoxin injection, LDL receptor mRNA had returned to levels similar to controls, and 18 and 24 h after endotoxin injection, they were increased by about 60% (P < 0.05). Separation of plasma lipoproteins by FPLC demonstrated that endotoxin-induced changes in plasma triacylglycerols and cholesterol were due to accumulation of plasma apolipoprotein B-containing lipoproteins among very-low-density lipoprotein, intermediate-density lipoprotein and LDL. It is concluded that endotoxin suppresses hepatic LDL receptor expression in vivo in rats.

References

    1. Adv Shock Res. 1983;9:43-7
    1. Biochem J. 1989 Sep 1;262(2):425-9
    1. Microbiol Immunol. 1982;26(11):1017-34
    1. Eur J Biochem. 1993 Feb 1;211(3):829-34
    1. Hepatology. 1992 Jul;16(1):224-31
    1. Metabolism. 1988 Sep;37(9):859-65
    1. Hepatology. 1993 May;17(5):898-907
    1. J Lipid Res. 1993 Dec;34(12):2147-58
    1. Am J Physiol. 1987 Jul;253(1 Pt 1):E59-64
    1. J Surg Res. 1984 Nov;37(5):394-401
    1. J Biol Chem. 1989 Jun 15;264(17):10264-70
    1. Microbiol Immunol. 1986;30(9):849-54
    1. J Lipid Res. 1991 Dec;32(12):1889-97
    1. J Clin Invest. 1993 Jun;91(6):2796-805
    1. J Biol Chem. 1991 Sep 25;266(27):18194-9
    1. J Biol Chem. 1993 Aug 15;268(23):17489-94
    1. Am J Physiol. 1985 Jun;248(6 Pt 1):E732-40
    1. Metabolism. 1976 Jun;25(6):615-24
    1. J Chromatogr. 1985 May 31;341(1):154-9
    1. Am J Med. 1991 Feb;90(2):154-62
    1. J Infect Dis. 1972 Jan;125(1):54-60
    1. Clin Chem. 1986 Jan;32(1 Pt 1):142-5
    1. J Lipid Res. 1993 Jan;34(1):139-46
    1. Biochem J. 1994 Feb 15;298 ( Pt 1):39-43
    1. Scand J Infect Dis. 1993;25(6):675-82
    1. Arch Surg. 1982 Feb;117(2):144-7
    1. Endocrinology. 1993 May;132(5):2246-53
    1. Eur J Biochem. 1994 Mar 1;220(2):349-57
    1. Proc Natl Acad Sci U S A. 1992 Aug 1;89(15):6983-7
    1. Mol Biochem Parasitol. 1980 Oct;2(1):31-8
    1. J Biol Chem. 1992 Jul 5;267(19):13160-5
    1. Scand J Gastroenterol. 1993 Feb;28(2):97-103
    1. Anal Biochem. 1983 Jun;131(2):385-93
    1. N Engl J Med. 1969 Nov 13;281(20):1081-6
    1. Diabetes. 1988 Oct;37(10):1386-91
    1. Microbiol Immunol. 1979;23(2):71-85
    1. J Lipid Res. 1992 Apr;33(4):493-501
    1. Proc Natl Acad Sci U S A. 1993 Oct 1;90(19):8851-5
    1. J Lipid Res. 1990 Jun;31(6):1099-107
    1. Anal Biochem. 1976 May 7;72:248-54
    1. Endocrinology. 1994 Apr;134(4):1685-92
    1. J Exp Med. 1959 Aug 1;110(2):293-309
    1. J Infect Dis. 1976 May;133(5):548-55
    1. Biochim Biophys Acta. 1992 Oct 30;1128(2-3):186-92
    1. J Lipid Res. 1964 Oct;5:563-8
    1. J Lipid Res. 1992 Dec;33(12):1765-76
    1. Biochem Biophys Res Commun. 1990 Nov 15;172(3):1022-7
    1. Curr Opin Lipidol. 1994 Jun;5(3):207-15

Source: PubMed

3
購読する